Filing Details
- Accession Number:
- 0001209191-11-032979
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-06-03 18:01:01
- Reporting Period:
- 2011-06-02
- Filing Date:
- 2011-06-03
- Accepted Time:
- 2011-06-03 17:01:01
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1160308 | Adventrx Pharmaceuticals Inc | [ANX] | Pharmaceutical Preparations (2834) | 841318182 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1310683 | M Brian Culley | 12390 El Camino Real Suite 150 San Diego CA 92130 | Chief Executive Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2011-06-02 | 5,000 | $2.44 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 1, 2010.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions executed by a broker-dealer at prices ranging from $2.41 to $2.48, inclusive. The reporting person will provide to the staff of the Securities and Exchange Commission, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Billionaire Hedge Funds
